SCHEMBL19851537

SCHEMBL19851537

CNC(=O)CNCc1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC3 O15379 1/20 0.53
HDAC2 Q92769 1/20 0.53
MC5R P33032 4/20 0.51
MC4R P32245 3/20 0.51
MC3R P41968 2/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPK1 P28482 1/20 0.48
IDO1 P14902 1/20 0.47
FFAR1 O14842 1/20 0.46
MC1R Q01726 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923929 0.86 HDAC8 (0.66) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL13021557 0.84 MC5R (0.54) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL6889945 0.82 FFAR1 (0.60) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL7446128 0.81 MEN1 (0.54) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL5848162 0.80 L3MBTL1 (0.60) MEN1KMT2AL3MBTL1
SCHEMBL4049756 0.80 ALDH1A1 (0.55) HDAC8HDAC1HDAC3HDAC2MEN1
SCHEMBL6172461 0.78 HDAC1 (0.57) HDAC8HDAC1FFAR1CYP1A2
SCHEMBL6008141 0.77 MC5R (0.71) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL5556807 0.76 KMT2A (0.57) HDAC8HDAC1HDAC3HDAC2MC5R
SCHEMBL7311581 0.74 HDAC1 (0.56) HDAC8HDAC1HDAC3HDAC2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026866-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION NEUROPORE THERAPIES, INC. (US) 2018-02-08 WO disclosed